Shares of GlaxoSmithKline were down nearly 8% on Monday after the British company announced that it has agreed to buy Tesaro, a cancer specialist company for $4.16 billion. New CEO of GSK, Emma Walmsley said to reporters, “This is an example of us executing on what we said we were going to do … to … Continue reading “GSK Sinks as It Agrees to Buy Tesaro for Around $4 Billion”
Tag: GlaxoSmithKline
Biotech & Pharma
GlaxoSmithKline to Buy Novartis AG’s Stake in Consumer-Health Joint Venture for $13B
One of the biggest headlines in the healthcare arena on Tuesday was that GlaxoSmithKline Plc,…
March 27, 2018
Biotech & Pharma
Pfizer to Sell its Consumer Healthcare Business in November
According to a Reuters report which cited two people close to the matter who remain…
October 26, 2017
Biotech & Pharma
GlaxoSmithKline (GSK) Filed To Get U.S. Approval For Triple Lung Drug
GlaxoSmithKline, tha largest drugmaker in Britain, announced on Monday that the company as filed its…
November 21, 2016